Profound Alterations of Intestinal Microbiota following a Single Dose of Clindamycin Results in Sustained Susceptibility to Clostridium difficile-Induced Colitis
Memorial Sloan Kettering Cancer Center · Core Laboratories (United States)
Abstract
Antibiotic-induced changes in the intestinal microbiota predispose mammalian hosts to infection with antibiotic-resistant pathogens. Clostridium difficile is a Gram-positive intestinal pathogen that causes colitis and diarrhea in patients following antibiotic treatment. Clindamycin predisposes patients to C. difficile colitis. Here, we have used Roche-454 16S rRNA gene pyrosequencing to longitudinally characterize the intestinal microbiota of mice following clindamycin treatment in the presence or absence of C. difficile infection. We show that a single dose of clindamycin markedly reduces the diversity of the intestinal microbiota for at least 28 days, with an enduring loss of ca. 90% of normal microbial taxa…
Citation impact
- FWCI
- 11.74
- Percentile
- 100%
- References
- 43
Authors
9- CGCharlie G. BuffieCorresponding
Memorial Sloan Kettering Cancer Center
- IJIrene Jarchum
Memorial Sloan Kettering Cancer Center
- MEMichele Equinda
Memorial Sloan Kettering Cancer Center
- LLLauren Lipuma
Memorial Sloan Kettering Cancer Center, Core Laboratories (United States)
- AGAsia Gobourne
Memorial Sloan Kettering Cancer Center, Core Laboratories (United States)
Topics & keywords
- Clindamycin
- Colitis
- Microbiology
- Biology
- Diarrhea
- Antibiotics
- Clostridium difficile
- Gut flora
- Good health and well-being